Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Age vs AMH-based Therapy in IVF
NCT01816789Phase 4Terminated
- Sponsor
- Andros Day Surgery Clinic
- Start
- Mar 2013
- Primary completion
- Jul 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of follitropin alfa in infertility (2 arms), sponsored by Andros Day Surgery Clinic. Primary endpoint: Percentage of women with an appropriate number (n=8-14) of retrieved oocytes in IVF/ICSI cycle at 24 months. Started Mar 2013; status: terminated.
02
Drugs
follitropin alfa
03
Conditions
infertility
Beyond the preview
Go deeper on NCT01816789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01816789.